Areas of Research: Immunity to encapsulated pathogens; antibody immunity; vaccine development
Professional Interests
Dr. Liise-anne Pirofski is a physician-scientist. Her research programs focus on immunity to encapsulated pathogens and antibody mediated immunity to infectious diseases.
She is chief of the Division of Infectious Diseases and the Jacques and Selma Mitrani Chair in Biomedical Research at Albert Einstein College of Medicine and Montefiore Medical Center. She is a member of the American Association of Physicians and a fellow of the American Academy of Microbiology, American College of Physicians, Infectious Diseases Society of America, and the American Association for the Advancement of Science. She is deeply devoted to biomedical education and mentoring for which she has received numerous accolades, including the American Society for Microbiology William A Hinton Award, and the Albert Einstein College of Medicine Faculty Mentoring Award, Harry Eagle Award for Outstanding Basic Science Teaching, and the Lifetime Achievement Award from the Albert Einstein College of Medicine Alumni Association.
Dr. Pirofski received Bachelor of Arts degrees from the University of California, Berkeley in History of Art and Psychology, and her Medical degree from the Albert Einstein College of Medicine, where she joined the faculty in 1990.
For more information, visit the Division of Infectious Diseases website.
More Information About Dr. Liise-anne Pirofski
Selected Publications
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
In the News
COVID Convalescent Plasma Finds a Therapeutic Role
Liise-anne Pirofski, M.D., co-authored a commentary on the benefits of convalescent plasma for treating immunocompromised patients who have COVID-19. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Early Use of Convalescent Plasma Reduced Hospitalizations, Raising Hopes for Treating Omicron Variant, Scientists Say
Liise-anne Pirofski, M.D., says the Federal Drug Administration should expand the use of convalescent plasma to outpatient use to help fight COVID-19, particularly during the current surge of the omicron variant. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Additional coverage includes The Scientist
More media coverage